Filing Details

Accession Number:
0001209191-20-051589
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-22 19:51:19
Reporting Period:
2020-09-22
Accepted Time:
2020-09-22 19:51:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1673772 Rapt Therapeutics Inc. RAPT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1606074 Peter Svennilson 1700 Owens Street
Suite 500
San Francisco CA 94158
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-09-22 608,000 $30.85 3,835,679 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,599,417 Indirect See footnote
Common Stock 145,401 Indirect See footnote
Common Stock 50,000 Indirect See footnote
Footnotes
  1. The securities are directly held by The Column Group II, LP ("TCG II LP") and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The Reporting Person is one of the managing partners of TCG II GP. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. The Reporting Person disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
  2. The securities are directly held by Ponoi Capital, LP ("Ponoi LP") and indirectly held by Ponoi Management, LLC ("Ponoi LLC"), the general partner of Ponoi LP. The Reporting Person is one of the managing partners of Ponoi LLC. The managing partners of Ponoi LLC may be deemed to have voting and investment power with respect to such shares. The Reporting Person disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
  3. The securities are directly held by Ponoi Capital II, LP ("Ponoi II LP") and indirectly held by Ponoi II Management, LLC ("Ponoi II LLC"), the general partner of Ponoi II LP. The Reporting Person is one of the managing partners of Ponoi II LLC. The managing partners of Ponoi II LLC may be deemed to have voting and investment power with respect to such shares. The Reporting Person disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
  4. The securities are directly held by The Column Group II Management, LP ("TCGM II LP"). The Reporting Person is one of the managing partners of TCGM II LP. The managing partners of TCGM II LP may be deemed to have voting and investment power with respect to such shares. The Reporting Person disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.